Dear guests & partners of Chisinau Business Forum,
We were just informed that, due to the high amount of COVID cases in Chisinau, it is no longer possible to organize business seminars, forums, meetings at this time.
In light of this news, we will POSTPONE the „Chisinau Business Forum” event for a later date, which we will communicate in advance.
We are sorry for any inconvenience caused by this announcement but the reason behind our decision is not in our control.
For any further information, please do not hesitate to contact us.
• Entrepreneurship development and increased investment are among the priorities recently announced by the new Government in Chișinau, led by Prime Minister Natalia Gavriliță. What are the expectations of the business environment to improve the investment climate and what concrete solutions are on the table of the authorities in this regard?
• Investments in infrastructure and digitalization of public services are two other main objectives assumed by the current government of the Republic of Moldova. What will be the anticipated impact of these measures on the economy?
• Romania is the main trading partner of the Republic of Moldova, the Romanian-Moldovan trade amounting to over 2 billion dollars in 2019. After the negative impact generated by the pandemic, bilateral trade returned to surplus, with an advance of 8.4% in first quarter of 2021. How can the dynamics of medium-term trade be strengthened and improved?
• Over 1,600 Romanian companies operate in the Republic of Moldova, and in Romania are registered more than 6,000 Moldovan companies. What are the economic sectors of interest for investors in Bucharest and Chișinau?
• Successful entrepreneurial stories.
Sponsors and Partners
- certificate of vaccination against COVID-19, with the complete vaccination scheme (paper or digital), valid 14 days after completion of the vaccination schedule;
- negative result of RT-PCR test, not older than 72 hours or of a rapid antigen test, not older than 48 hours;
- medical conclusion confirming that the person has had COVID-19 between day 15 and day 180 (6 months);
- confirmation of the presence of anti-COVID-19 antibodies, valid for 90 days from the date of the investigation.